ALFA FinderBSE filing, NSE: GSPCROP. Summary written from the filing by ALFA Finder's alert engine.
GSP Crop Science Ltd: key numbers
- Share price
- ₹438.70
- Market cap
- ₹2,041 Cr
- Revenue (annual)
- ₹1,517 Cr
- Net profit (annual)
- ₹97.90 Cr
- P/E (TTM)
- 23.7×Sector 35.1×
- Promoter holding
- 71.73%+0.00% QoQ
- FII holding
- 9.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GSP Crop Science Ltd
All →GSP Crop Science Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹5,584 Mn (+19.5% YoY), but EBITDA fell 21% to ₹736 Mn, margin 13.2% (vs 19.9%). PAT ₹446 Mn, down about 24%.
GSP Crop Science Results Update
GSP Crop Science released Q2 and H1 FY27 results highlights, showing revenue growth but lower profit. Margins were pressured by input costs and uneven monsoon conditions.
GSP Crop Science Management Change
GSP Crop Science appointed Shail Shah as CFO and Executive Director of Finance. Rajesh Naduvath ceased as Head of International Business, effective 13 November 2026.
GSP Crop Science Q2 FY27 Results: Net Profit ₹44.6 Cr, Down 23.8% YoY
GSP Crop Science Ltd reported revenue from operations of ₹558.4 Cr (+19.5% YoY) and net profit of ₹44.6 Cr (-23.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹44.6 Cr · -23.8% YoY
GSP Crop Science Board Meeting Date
GSP Crop Science has intimated a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closure is also referenced, with agenda items only proposed.
GSP Crop Science Other Announcement
GSP Crop Science filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Promoter and promoter group hold 71.73% of equity, a routine compliance disclosure.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr